The oral glucose tolerance test (OGTT) is performed in patients in whom abnormalities of glucose metabolism are suspected, but the criteria for diagnosing diabetes are not yet met. It is also routinely carried out in the management of diseases associated with a more or less pronounced disturbance of glucose intolerance. According to the current guidelines, during OGTT glycemia is measured before and two hours after the administration of glucose. In pregnancy, three measurements are obligatory (0', 60', 120'). When additional indications are present, glycemia is assessed also 30 minutes after the administration of glucose and when reactive hypoglycemia is suspected, the test is extended to 180 minutes. As of late, it is becoming a more and more common practice to measure blood glucose also 60 minutes post-administration. This technique is more reliable for the assessment of glucose tolerance disturbance. It seems sensible to introduce a recommendation of such measurement as a routine practice. (clin Diabetol 2016; 5, 4: 127-130)
Introduction
The criteria for diagnosing diabetes are established. According to the current guidelines, a random plasma glucose ≥ 200 mg/dL (11.1 mmol/L) is sufficient enough to diagnose this disease [1, 2] . In 2003, the American Diabetes Association defined the threshold for the identification of IFG (impaired fasting glucose) at 100 mg/dL (5.6 mmol/L) -and those recommendations are still valid [3] .
A recognition of other disorders is an indication for additional investigations. A basic test for identifying the level of glucose metabolism impairment is the oral glucose tolerance test (OGTT). The measurement of glycemia is carried out before the oral administration of glucose and then, based on the WHO recommendations from the year 1999, at 2 hours post-administration. The test has undergone modifications over the years and thus, for example, during pregnancy it is obligatory to perform three glucose measurements at 0, 60 and 120 minutes [2, 4] .
In the case of special indications (simultaneous insulin secretion assessment), glycemia is also measured at 30 minutes post glucose administration. If reactive hypoglycemia is being diagnosed, the test is prolonged to 180 minutes. The OGTT is performed in patients with confirmed impairment of glucose metabolism or in whom such impairment is suspected -if the typical criteria for diagnosing diabetes are not met. This includes patients with IFG (impaired fasting glucose -glycemia in the 100-125 mg/dL or 5.6-6.9 mmol/L range) or IGT (impaired glucose tolerance -glycemia at 2 hours of OGTT in the 140-199 mg/dL or 7.8-11.1 mmol/L range) [5] .
The American authors presented interesting research in which it was pointed out that the recognition of IFG in children can be considered a forecast of type 2 diabetes in adolescence [6] .
OGTT is also routinely performed in states, in which concomitant glucose intolerance may be present (endocrine disorders, pancreatic diseases, genetic syndromes, use of medication known to impair glucose metabolism).
In practice, it is more and more common to routinely measure glycemia also at the 60 minute mark of the OGTT [7] . This gives a more reliable basis for the assessment of glucose tolerance impairment. There have been reports to suggest, that such modification of the OGTT is useful especially in the prognosis of the development of type 2 diabetes [8] [9] [10] . The Authors, after analyzing data from 7-8 years, concluded that the measurement of glycemia at 1 hour of OGTT is a better predictor of type 2 diabetes risk that the classic assessment at 2 hours. Similar observations concerning the 1-hour post administration measurement were reported by different authors [11] . In particular, Italian authors studied the importance of early OGTT measurement for the prediction of diabetes development in children [12] . They set the 1-hour OGTT threshold for recognizing diabetes risk in juvenile obese patients at ≥ 132.5 mg/dL (≥ 7.4 mmol/L). The Chinese authors reported a higher risk of metabolic disorders if 1-hour OGTT value was ≥ 154.8 mg/dL (≥ 8.6 mmol/L) [13] . Similar prediction thresholds for 1-hour OGTT were reported by other researchers [14] .
Recently, results have been published on the relationship between 1-hour OGTT values, the assessment of beta-cell function and insulin sensitivity [15] .
Italian authors published research on the risk of renal dysfunction and its association with early OGTT measurement values [16] .
The border 1-hour post-load value for recognizing increased risk of metabolic syndrome was recently established at 158.4 mg/dL (8.85 mmol/L) [17] .
Clinical cases
Below are a few clinical examples which illustrate the importance of 1-hour post-load OGTT measurement for the prognosis of diabetes development (Tab. 1-6).
Discussion
An analysis of the cases presented above suggests an exceptional utility of 1-hour post-load OGTT measurement. It is important to notice that due to the lack of established reference values for such measurement, its results are often ignored which delays the introduction of adequate treatment [2] .
It seems that the assessment of early OGTT values would, in many cases, provide an indication for the beginning of therapy.
Conclusion
More and more authors point out to the utility of 1 hour post-load OGTT glucose measurement in prognosing the development of type 2 diabetes, cardiovascular diseases, renal failure and other disorders in patients who do not fulfill the criteria for diagnosing diabetes. The literature on this subject is abundant. In this situation it would seem reasonable to include an obligatory 1 hour post-load glucose measurement in every case when OGTT is performed. 
